PF
KURA icon

Phoenix Financial’s Kura Oncology KURA Stock Holding History

Phoenix Financial’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-169,750
Closed -$2.38M – 428
2021
Q4 		$2.38M Sell
169,750
-5,250
-3% -$85.1K 0.04% 185
2021
Q3 		$3.28M Buy
175,000
+80,000
+84% +$1.51M 0.06% 165
2021
Q2 		$1.98M Buy
+95,000
New +$2.36M 0.04% 214

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Phoenix Financial's KURA Position: Q1 2022 in Review

Phoenix Financial sold out of Kura Oncology (KURA) in Q1 2022, closing a stake of 169,750 shares — an estimated $2.38M sold.

Phoenix Financial first reported a position in KURA in Q2 2021 and held it in 3 quarters. The position peaked at $3.28M in Q3 2021. 152 funds tracked by Wall St. Rank hold KURA as of Q1 2022.

  • Phoenix Financial reported no remaining Kura Oncology position as of Q1 2022 after selling out during the quarter.
  • Phoenix Financial sold 169,750 Kura Oncology shares in Q1 2022, an estimated $2.38M.
  • Phoenix Financial first reported a position in Kura Oncology in Q2 2021 and held it in 3 quarters.
  • Phoenix Financial's Kura Oncology position peaked at $3.28M in Q3 2021.
  • 152 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2022.

Based on Phoenix Financial's 13F filing for Q1 2022, filed 10 May 2022.